There will NOT be a clinical trial this year in Saskatchewan of the “liberation therapy” for multiple sclerosis. From the StarPhoenix:
The Saskatchewan Party government has been in the lead on the issue nationally, with Premier Brad Wall last year announcing $5 million for clinical trials of the therapy, which involves angioplasty to widen neck veins.
In December, the Saskatchewan Health Research Foundation (SHRF) issued a call for proposals and the province said clinical trials should begin later this year.
But on Wednesday both the foundation and the Saskatoon-based research team that had made the single proposal to the SHRF said more scientific research is needed before a broad trial such as the one proposed in Saskatchewan could move ahead.